|
MRPL41 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.362400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.358100E-03 |
| Normal-vs-Stage2 |
3.581400E-01 |
| Normal-vs-Stage3 |
7.373400E-01 |
| Normal-vs-Stage4 |
3.890800E-01 |
| Stage1-vs-Stage2 |
3.885200E-01 |
| Stage1-vs-Stage3 |
3.847600E-02 |
| Stage1-vs-Stage4 |
6.479600E-01 |
| Stage2-vs-Stage3 |
5.601600E-01 |
| Stage2-vs-Stage4 |
8.384600E-01 |
| Stage3-vs-Stage4 |
4.872000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.143500E-03 |
| Normal-vs-AfricanAmerican |
6.352300E-02 |
| Normal-vs-Asian |
6.183200E-01 |
| Caucasian-vs-AfricanAmerican |
9.120400E-01 |
| Caucasian-vs-Asian |
4.720400E-02 |
| AfricanAmerican-vs-Asian |
6.317700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.759190E-03 |
| Normal-vs-Female |
5.313200E-01 |
| Male-vs-Female |
8.975500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.512100E-02 |
| Normal-vs-Extreme_Weight |
5.379700E-04 |
| Normal-vs-Obese |
3.073000E-01 |
| Normal-vs-Extreme_Obese |
2.698400E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.561000E-01 |
| Normal_Weight-vs-Obese |
3.846200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.177700E-02 |
| Extreme_Weight-vs-Obese |
4.071800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.244050E-01 |
| Obese-vs-Extreme_Obese |
1.414400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.491800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.636200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.304330E-03 |
| Normal-vs-Age(81-100Yrs) |
9.743200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.679400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.061800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.681200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.186250E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.075160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.599000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.24849999999455E-05 |
| Normal-VS-Type2 PRCC |
5.981400E-01 |
| Normal-VS-KIRP CIMP |
4.935700E-02 |
| Normal-VS-Unclassified PRCC |
3.242400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.462100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.539600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.803410E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.134200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.037000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.310020E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.997900E-02 |
| Normal-vs-N1 |
5.113800E-01 |
| Normal-vs-N2 |
1.940960E-01 |
| N0-vs-N1 |
3.753800E-02 |
| N0-vs-N2 |
1.171040E-01 |
| N1-vs-N2 |
5.917000E-01 |
|
|
